卫宁健康：医疗IT短期承压，互联网业务持续增长！

Investment Rating - The report maintains an "Outperform" rating for the company [10] Core Views - The company reported a slight revenue increase of 0.65% year-on-year for the first three quarters of 2024, with total revenue reaching 1.913 billion yuan [8] - The net profit attributable to the parent company for the same period was 155 million yuan, reflecting a year-on-year growth of 1.51% [8] - The company's internet health business showed significant growth, with a revenue increase of 52.68% year-on-year for the first three quarters [9] - The company is entering a full promotion phase for its enhanced WiNEX product, which is expected to expand its order volume and enhance core competitiveness [9][10] Financial Summary - Total revenue for 2023 was 3.163 billion yuan, with projections of 3.516 billion yuan for 2024, 4.090 billion yuan for 2025, and 4.752 billion yuan for 2026 [12] - The net profit attributable to the parent company is expected to grow from 358 million yuan in 2023 to 474 million yuan in 2024, 620 million yuan in 2025, and 781 million yuan in 2026 [12] - The gross profit margin is projected to stabilize around 44% for the next few years, with a slight increase to 45.1% by 2026 [6][12]